Interestingly, myoferlin was previously reported to regulate the TGF-β autocrine loop in breast cancer cells [41], and Smad2, a downstream transducer, was recently reported as a mitofusin interactor in mitochondrial fusion [42]. Here, SMAD2 is linked to breast cancer.